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Most multiple sclerosis (MS) patients develop over time a secondary progressive dis-
ease course, characterized histologically by axonal loss and atrophy. In early phases of 
the disease, focal inflammatory demyelination leads to functional impairment, but the 
mechanism of chronic progression in MS is still under debate. Reactive oxygen species 
generated by invading and resident central nervous system (CNS) macrophages have 
been implicated in mediating demyelination and axonal damage, but demyelination and 
neurodegeneration proceed even in the absence of obvious immune cell infiltration, 
during clinical recovery in chronic MS. Here, we employ intravital NAD(P)H fluorescence 
lifetime imaging to detect functional NADPH oxidases (NOX1–4, DUOX1, 2) and, thus, to 
identify the cellular source of oxidative stress in the CNS of mice affected by experimental 
autoimmune encephalomyelitis (EAE) in the remission phase of the disease. This directly 
affects neuronal function in vivo, as monitored by cellular calcium levels using intravital 
FRET–FLIM, providing a possible mechanism of disease progression in MS.
Keywords: nOX, eae/Ms, intravital imaging, FliM–FreT, calcium
inTrODUcTiOn
Multiple sclerosis (MS) is a chronic neuroinflammatory disease, with most patients exhibiting a 
relapsing and remitting course of disease. The neurological damage is a consequence of a mainly 
T cell-driven immune reaction against myelin in the central nervous system (CNS) (1). Macrophages/
microglia, B, and T cells create an acute inflammatory setting, resulting in demyelination and 
neuronal damage. Most of the patients who experience a second episode develop further relapses. 
Despite the intensive analysis of the acute immune attack, only little is known about the processes 
going on at the lesion site after the initial insult (2, 3).
Why and where do new relapses appear? What factors determine the chronicity of a lesion and 
the course of disease? “Old” lesions appear morphologically inert and are characterized by single 
perivascular T cells, minimal axonal damage in histological stainings with anti-amyloid precursor 
protein (APP) antibodies and a dominant fibrotic glial scar (4, 5). In contrast to the progressive 
disease phase, the inflammatory phase is well modeled by murine experimental autoimmune 
encephalomyelitis (EAE). In this mouse model using an immunization with MOG35–55 peptide, acute 
clinical signs remit after a few days and mice enter into a chronic phase with or without a residuum 
of neurological deficits (1). Reactive oxygen species (ROS) generated by invading and resident CNS 
macrophages have been implicated in mediating demyelination and axonal damage (6–8). In this 
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study, we address implications of the ceased immune attack for 
the CNS tissue, beyond the fact that the majority of peripheral 
immune cells disappeared. In MS patients, we previously detected 
an ongoing over-activation of NADPH oxidases (especially 
NOX2) in blood monocytes during remission (8). Using intravital 
NAD(P)H fluorescence lifetime imaging in mice affected by EAE, 
during the inflammatory phase (onset and peak of the disease), 
we detected a massively increased amount of functional NADPH 
oxidases (NOX1–4, DUOX1, 2) within the CNS as compared to 
healthy controls (8). Using the same method, we investigated 
whether functional NADPH oxidases are still present in the 
CNS after recovery of EAE and, thus, whether oxidative stress 
is still ongoing in absence of peripheral infiltration of the CNS. 
We simultaneously monitor calcium concentrations in neurons 
using intravital FRET–FLIM-based neuronal calcium imag-
ing to evaluate the reaction of the neurons on the altered CNS 
environment over the course of EAE development and remission. 
Thereby, we investigate whether in mice with clinical recovery 
morphologically inert appearing lesions exhibit residual inflam-
mation, as reflected by increased oxidative stress and sub-clinical 
neuronal dysfunction, in order to better understand mechanisms 
of chronicity and disease progression in MS and related diseases.
resUlTs
characterization of the remission Phase 
in the cns of Mice affected by eae
The grade of inflammation in brain stem of mice with EAE after 
clinical recovery (remission) was characterized and compared 
to animals at the peak of disease and to healthy controls. Our 
aim was to first characterize peripheral and CNS resident cellular 
compartments during the remission phase by means of intravital 
imaging and to corroborate previous results concerning the lack 
of overt inflammation in this phase.
characterization of cellular Markers in the 
cns, during eae remission
It is widely accepted that in MS, inactive CNS lesions with no 
signs of immune infiltration are detectable. In our EAE model, 
some mice show a complete clinical recovery of EAE signs. We 
characterized these mice by FACS analysis of whole murine CNS 
(brain and spinal cord) and demonstrated that both monocytes/
macrophages (CD45highCD11b+ cells) and T cells (CD45highCD3+ 
cells) disappear from the CNS during the remission phase of EAE. 
Only 7.9 ± 2.8% of the isolated CNS cells were CD45highCD11b+ 
cells (macrophages/monocytes), comparable with healthy con-
trols with 6.2 ±  2.4% (Figures 1A,B), whereas their frequency 
during onset and peak of EAE was previously shown to be strongly 
increased, to ~50% of the infiltrates (8–10). The majority of cells 
after EAE recovery were cells with characteristics of microglia: 
72.5 ± 3.6% were CD45lowCD11b+ of which 95.2 ± 6.7% expressed 
CX3CR1. The overlap of CX3CR1 and tdRFP (LysM) was in 
both compartments under 5% (3.5 ± 3.2% for CD45highCD11b+ 
cells and 3.5 ±  3.1% for CD45lowCD11b+ cells). CD45highCD3+ 
cells –  typically present during the peak of EAE (11) – mainly 
disappeared after EAE recovery, constituting only 0.2 ±  0.1% 
of total cell number. All these findings are in line with the low 
clinical scores of the mice (between 0 and 0.5; Table 1) and are 
consistent with previous observations of cellular compositions 
after EAE recovery (10). Our results encompass two independent 
EAE experiments with a total number of n = 3 mice analyzed in 
remission phase (Table 1) and n = 5 analyzed healthy mice.
Using intravital microscopy in CX3CR1+/− EGFP mice 
(n = 3) after EAE recovery, we could show a reduced overlap of 
3.6 ± 1.8% between EGFP and i.v. injected sulforhodamin 101 
(SR101), which labels astrocytes both in health and in peak EAE 
(8). These results are similar to the overlap measured in healthy 
CX3CR1+/−EGFP mice labeled by i.v. injection with SR101 
(2.7 ± 1.1% overlap, Figure 1C).
intravital imaging reveals Morphologic 
Features of eae remission in the cns
We performed intravital imaging experiments in the brain stem 
of CerTN L15 × LysM tdRFP mice (neurons express the Ca2+ indi-
cator TN L15, while predominantly LysM+ phagocytes express 
tdRFP) and of CX3CR1+/− EGFP mice (microglia/macrophages 
express EGFP, while predominantly astrocytes are labeled by 
SR101).
Infiltration of the CNS by LysM+ cells is transient, and varies 
with the stage of disease. In health, practically no LysM+ cells 
are present except for few perivascular LysM+ microglia. During 
peak of EAE, many LysM+ cells are present within CNS lesions, 
and they mostly disappear during the remission phase. We could 
only identify isolated regions where LysM+ cells were present 
inside or in the close proximity to blood vessels or meninges 
(Figure 2A).
In contrast to the peripheral immune cells, the inflammatory-
induced gliosis of CNS-resident cells [microglia and astrocytes 
having phagocytic capacity (8)] persists after EAE recovery 
(Figure 2B). We evaluated shape and function of astrocytes and 
microglia to test our hypothesis that the function of these CNS 
cells, in chronic neuroinflammation, has persistently (patho-
logically) elevated phagocytic features, even in the absence of 
peripheral immune cells.
First, we quantitatively analyzed the shape of microglia, based 
on the fact that resting microglia, typical for healthy CNS, are 
highly ramified, whereas activated microglia, especially those 
having a phagocytic function, lose their cellular processes and 
adopt an amoeboid shape. The amoeboid shapes are expected to 
be found especially in the diseased CNS (10).
We used Fourier coefficients to quantify and reproduce the 
ramified shape of microglia and to quantify their shape changes 
in the remission phase as compared to health and peak of the 
disease. Briefly, single microglia cells were segmented from intra-
vital microscopy data acquired in the brain stem of healthy and 
EAE mice (in peak and remission phase). Six two-dimensional 
projections from each three-dimensional object (cell) were gen-
erated, and their shape was approximated by overlapping circles 
as displayed in Figure 2C. Each layer of circles is mathematically 
characterized by a scalar parameter called Fourier coefficient. 
Thus, the first Fourier coefficient defines the position of a cell, the 
second defines its dimensions by approximating it with a perfect 
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FigUre 1 | Peripheral immune infiltration of the cns has largely resolved in the remission phase of eae. (a) FACS analysis of CNS cells after recovery of 
EAE shows a low immune infiltrate with few monocytes/macrophages (CD45highCD11b+; MP) and CD3+ cells. Most of the CD45 expressing cells are CD45lowCD11b+ 
(microglia; MG). CD45highCD11b+ frequencies are comparable to healthy untreated mice (n = 5; ±SD). We applied an unpaired t-test to statistically evaluate the 
results. In the CD45highCD11b+ fraction (MP), only few cells express CX3CR1 but most of the cells in the CD45lowCD11b+ fraction (MG). The overlap of CX3CR1 and 
tdRFP was comparable in both cell types around 3% (n = 3; ±SD, clinical information listed in Table 1) (B) Exemplarily gating strategy of the FACS analysis of whole 
CNS in mice after recovery of EAE. (c) Projection of 3D intravital fluorescence image in the brain stem of a CX3CR1+/− EGFP mouse in health and during the 
remission phase of EAE. The astrocytes (and blood vessels) are labeled by i.v. injected SR101 (red), while the microglia are expressing EGFP (green). Scale 
bar = 50 μm. The colocalization of the EGFP and SR101 signals, i.e., overlap of the microglial and astrocytic markers, respectively, amounts to 3.6 ± 1.8%.
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sphere, and the next Fourier coefficients define the number and 
length of cellular processes. Each cellular process is approxi-
mated by a set of spheres of various diameters, with the center 
on the surface of the most distant, previous sphere (Figure 2C). 
The higher the ramification and the length of cellular processes, 
the larger are the relative values of the high-order Fourier coef-
ficients with respect to the second Fourier coefficient. We found 
a high shape similarity of microglia during the remission phase 
(118 cells) and of those imaged at the lesion site, at the peak of the 
disease (57 cells). In comparison to resting microglia in healthy 
controls (71 cells), the similarity was rather low (Figure  2D). 
The third, fourth, and fifth Fourier coefficients show a significant 
difference (using an ANOVA test) both in remission and in 
peak as compared to healthy controls. The results encompass 
two independent EAE experiments with n = 3 healthy controls, 
n = 2 mice at peak EAE, and n = 4 mice during the remission 
phase. The findings of our intravital experiments demonstrate 
that in remission, after clinical recovery, microglia retain an 
TaBle 1 | Mouse strains, eae data of the mice and mean nOX activation area values within lesions or gliosis/astrogliosis areas with sD per animal 
(6–20 areas within the brain stem per animal).
eae iD Mouse strain eae score at analysis 
time point
Maximum eae score Mean nOX activation 
area (%)
sD
1 CX3CR1.EGFP 1.5 1.5 17.88 5.13
1 CerTN L15 × LysM tdRFP 1.0 1.0 13.20 1.06
1 CerTN L15 × LysM tdRFP 0.5 2.0  8.15 2.25
2 CerTN L15 × LysM tdRFP 2.5 2.5 16.99 9.02
2 CerTN L15 × LysM tdRFP 0.5 1.5  9.91 3.97
3 CerTN L15 × LysM tdRFP 2.0 2.0 10.65 0.51
3 CerTN L15 × LysM tdRFP 2.0 2.0  7.18 1.42
3 CX3CR1.EGFP 1.5 1.5 11.61 1.34
3 CX3CR1.EGFP 0.0 1.5  9.27 3.25
3 CX3CR1.EGFP 0.0 1.0  8.77 3.97
4 CX3CR1.EGFP 0.0 2.0 11.53 5.38
4 CX3CR1.EGFP 0.0 1.5  9.71 2.79
4 CX3CR1.EGFP 0.5 2.0 12.19 4.65
4 CerTN L15 × LysM tdRFP 0.0 2.0 – –
5 CerTN L15 × LysM tdRFP 0.5 3.5 – –
5 CerTN L15 × LysM tdRFP 0.5 3.5 – –
healthy 
controls
Mouse strain Mean nOX activation 
area (%)
sD
1 CerTN L15 × LysM tdRFP 0.37 0.13
2 C57BL/6 2.84 0.29
3 CerTN L15 × LysM tdRFP 0.47 0.09
4 C57BL/6 0.60 0.28
5 CerTN L15 × LysM tdRFP 2.08 0.91
We included five independent EAE experiments and five healthy controls for the intravital NAD(P)H–FLIM experiments.
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activated morphology, suggesting that their function remains 
predominantly phagocytic despite the fact that clinical symptoms 
disappeared.
Consistent with the results of shape analysis of microglia, the 
astrocytic network appears intact in healthy controls (n =  2), 
whereas during peak EAE (n  =  4) and the remission phase 
(n = 3), it appears disrupted (Figure 2E). Additionally, the fine 
astrocytic processes completely disappear and are replaced by 
thick perivascular processes, while the astrocytic cell bodies 
adopt ameboid shapes (Figure  2E). A quantification of these 
observations is rather difficult. Even if a good segmentation of 
the single astrocytes and their processes is given, currently there 
is no available mathematical approach or set of mathematical 
parameters to summarize the complexity of the profound changes 
of the astrocytic network. However, altogether the observations 
regarding morphological modifications suggest that the astro-
cytes are also shifted toward a phagocytic function.
subclinical neuronal Dysfunction 
correlates with Oxidative stress without 
Overt immune infiltration after recovery 
of eae
Altered morphology often indicates functional changes, but 
morphology is not a direct measure of the cellular function. To 
evaluate alterations in cellular function over the course of EAE, 
we used intravital NAD(P)H fluorescence lifetime imaging 
(FLIM), as previously described (8), to detect the over-activation 
of NADPH oxidases (NOX1–4, DUOX1, 2). As we previously 
showed in intravital imaging experiments of mice affected by EAE, 
a concentration of ~200 μM of ROS is detectable in the brain stem, 
in EAE, using local ROS labeling with Amplex Red. In contrast, 
in healthy animals, we could not detect any ROS generation. As 
ROS molecules are highly reactive and diffusive, their detection is 
limited and the analysis of their cellular source practically impos-
sible. We circumvent this disadvantage by detecting the catalyzer 
of ROS production, i.e., NOX enzymes, using NAD(P)H–FLIM 
in vivo. We previously showed that high ROS concentration in the 
brain stem of EAE animals correlates with the over-activation of 
NOX enzymes as detected by intravital NAD(P)H–FLIM (12). 
The fluorescence lifetime of NADPH bound to NADPH oxidases 
is ~3650  ps (12), differing from generally active NADH- and 
NADPH-dependent enzymes [fluorescence lifetime of NAD(P)H 
~2200 ps]. The over-activation of NADPH oxidases is a prereq-
uisite of oxidative stress – known to be one of the main causes 
of neuronal dysfunction in chronic neuroinflammation (6, 13).
In healthy mice, intravital NAD(P)H–FLIM of the brain stem 
reveals predominantly metabolic enzyme activity (8). At peak 
of EAE, the lesion site is associated with vast areas of activated 
NADPH oxidases, leading to increased oxidative stress (8). 
Surprisingly, even if overt inflammation and the clinical symp-
toms disappear, a local activation of NADPH oxidases does not 
decline to levels found in healthy mice. While the area of NOX 
enzymes activation in the brain stem of healthy mice amounts in 
average to 1.8 ± 1.3%, the same average value at peak of the dis-
ease significantly increases eightfold to 15.6 ± 5.1% and declines 
only slightly to 9.4 ± 1% during the remission phase, still over 
fivefold higher than in healthy mice (Figures 3A,C).
BA
healthy peak EAE remission EAE
Thy 1
LysM
CX3CR1
E
SR101
x x x2.
3.
4.
5.
Fourier coefficients
cell body
C
cell process
D
1 2 3 4 5 6 7
0,1
1  peak EAE
 healthy
 remission EAE
re
l. 
va
lu
e 
of
 F
ou
rie
r c
oe
ffi
ci
en
ts
Fourier coefficient ID
healthy peak EAE remission EAE
*
*
**
FigUre 2 | intravital imaging reveals that remission in eae correlates with lack of overt immune infiltration, with persisting disruptions of the 
microglial and astrocytic networks. (a) 3D intravital fluorescence images in the brain stem of CerTN L15 × LysM tdRFP mice in health (n = 5), at peak EAE 
(n = 6) and in the remission phase (n = 2). λexc = 850 + 1110 nm, λem = 525 ± 25 nm (Thy1-Citrine in neurons depicted in green), λem = 593 ± 20 nm (LysM tdRFP in 
phagocytes depicted in red), scale bar = 50 μm. (B) 3D intravital fluorescence images in the brain stem of CX3CR1+/− EGFP mice in health (n = 3), at peak EAE 
(n = 4) and in the remission phase (n = 5). λexc = 935 nm, λem = 525 ± 25 nm (CX3CR1+/− EGFP in microglia/macrophages depicted in green), scale bar = 50 μm. 
(c) Using higher-order Fourier coefficients, we describe the complex shape of microglia. The first Fourier coefficient describes the position of the cells, the second 
coefficient the sphericity of the cell body and starting from the third Fourier coefficient, the ramification of all cell processes is reproduced: the higher the values of 
high-order Fourier coefficients with respect to the second Fourier coefficient, the higher the degree of ramification and length of cellular processes of microglia.  
(D) The different shapes of the microglia, shown in (B), were classified in health (71 cells) at peak EAE (57 cells) and in its remission phase (63 cells). The difference 
between the values of the third, fourth, and fifth Fourier coefficients is significant between healthy controls and remission, but not significant between peak of EAE 
and remission of EAE. Statistical significance was determined by ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001). (e) Projection of 3D intravital fluorescence images in 
the brain stem of C57/B6 mice i.v. injected with sulforhodamine 101 (SR101) in health (n = 2), at peak EAE (n = 4) and in the remission phase (n = 3). λexc = 880 nm, 
λem = 593 ± 20 nm (SR101 in astrocytes depicted in red), scale bar = 50 μm.
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FigUre 3 | nOX enzymes activation correlates with neuronal dysfunction in the remission phase of eae. (a) τ2 (enzyme-bound) NAD(P)H–FLIM images 
acquired in the brain stem of healthy mice (n = 5) and of mice affected by EAE at peak of the disease (n = 6) and in the remission phase (n = 7). The results 
encompass four independent EAE experiments. Scale bar = 30 μm. (B) Intravital fluorescence intensity image, NAD(P)H–FLIM image and FRET–FLIM neuronal 
calcium image acquired in the brain stem of a CerTN L15 × LysM tdRFP mouse in the remission phase of EAE. Scale bar = 30 μm. (c) Quantification of the mean 
NOX activation area of individual mice at peak EAE (n = 6) and in the remission phase (n = 7), four independent EAE experiments. While the mean are of NOX 
activation is strongly increased in the remission phase of EAE as compared to healthy controls, we could observe only a slight decrease of the NOX activation area 
as compared to peak of EAE (at lesion sites). (D) Quantification of the neuronal dysfunction area characterized by a neuronal calcium concentration larger than 1 μM 
at peak EAE (n = 4) and in the remission phase (n = 2), two independent EAE experiments. The area of elevated neuronal calcium (area of neuronal dysfunction) is 
slightly reduced in the remission phase of EAE as compared to the peak of the disease. However, since in healthy controls there is no elevated neuronal calcium, in 
both phases of EAE, the elevated calcium indicates massive neuronal dysfunction. (e) Direct correlation between NOX enzymes over-activation area and neuronal 
dysfunction area in the remission phase of EAE, within the brain stem (n = 2 mice). All images are acquired at 30–150 μm depth within the brain stem (z-
step = 2 μm). (F) Intravital 3D images of the brain stem of a CerTN L15 × tdRFP mouse affected by EAE, at peak of the disease, at an arbitrary time point t = 0 and 
120 min later. The upper panels show intensity images of axons (cyan, Thy1) and of immune cells (red), whereas the lower images show the corresponding FRET 
ratio images (Calcium images) of the axons. At the contact sites between axons and immune cells, we observe strongly increased neuronal calcium. After 2 h, at 
exactly these sites, we observed dramatic morphological changes of the axons, i.e., appearance of ovoid bodies and axonal disruption. The axonal disruption and 
ovoid bodies formation along the axon is indicated by white arrows in the lower panels of (F). Statistical evaluation in (c,D) was determined by ANOVA tests 
(*p < 0.05, **p < 0.01, ***p < 0.001).
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To determine if this increased activation of NAD(P)H oxidases 
was associated with subclinical neuronal dysfunction, we deter-
mined the neuronal calcium level using intravital FRET–FLIM in 
the brain stem of CerTN L15 × LysM tdRFP mice affected by EAE, 
as previously described (8, 14, 15). Associated with the persisting 
oxidative stress, we observed increased neuronal calcium indi-
cating subclinical neuronal dysfunction, and progressing to neu-
ronal damage, within the areas of elevated oxidative stress. The 
area of measured neuronal dysfunction in the remission phase 
(6.2 ± 1.7%) is lower than at peak of disease (11.7 ± 2.8%) (16), 
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FigUre 4 | cellular origin of oxidative stress in the remission phase of eae. (a) Intravital fluorescence images and enzyme-bound NAD(P)H fluorescence 
lifetime images of all cells and of specific cell subtypes acquired in the brain stem of transgenic mice affected by EAE, in the remission phase. We evaluated CerTN 
L15 × LysM tdRFP mice, in which neurons Thy1 express the calcium indicator TN L15 and LysM+ phagocytes express tdRFP, and CX3CR1+/− EGFP mice, in which 
microglia/macrophages express EGFP. Astrocytes were intravitally labeled with sulforhodamine 101 by i.v. injection at least 2 h before imaging. The white lines in the 
fluorescence and fluorescence lifetime images at the bottom of (a) demarcate the outline of a blood vessel. Hence, it becomes obvious that most of LysM+ cells 
reside within the blood vessels, and only few can be found at the border to the CNS parenchyma. Scale bars = 50 μm. (B) Contribution of the individual cell subsets 
to the over-activation of the NOX enzymes in the CNS of mice during the remission phase of EAE (n = 2 CerTN L15 × LysM tdRFP mice – neurons/Thy1 and LysM; 
n = 5 CX3CR1+/− EGFP mice – microglia/CX3CR1 cells; n = 3 mice labeled with sulforhodamine 101 – astrocytes). The results encompass four independent EAE 
experiments.
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in line with higher scores during peak than in the recovery phase 
(Table 1); however, it is significantly higher than in healthy mice, 
in which no neuronal dysfunction can be observed using the 
same approach (Figures 3B,D) (14). As depicted in Figure 3E, 
in regions with no or very low over-activation of NOX enzymes 
(<4% of the total observed area), no neuronal dysfunction can 
be detected. Beyond this value, the oxidative stress regime is 
established and neuronal dysfunction linearly increases with 
increasing area of NOX enzymes activation, within the CNS 
(Pearson’s R = 0.90883).
As we and others previously demonstrated, a sustained elevated 
calcium concentration in neurons, both in vivo and in primary 
neuronal cultures, can precede morphological changes and finally 
neuronal death. In the brain stem of a CerTN L15 × LysM tdRFP 
mouse affected by EAE, enhanced contact of axons with periph-
eral LysM cells correlate with an increased calcium baseline in 
axons (Figure 3F). Imaging over 2 h reveals after recovery of EAE 
sites of increased calcium concentration do not correlate with 
dramatic morphological changes such as ovoid bodies or even 
axonal disruption, in contrast to the situation in peak EAE as 
depicted in Figure 3F (white arrows). Since the TN L15 geneti-
cally encoded biosensor reacts slowly to calcium (within few 
hundred milliseconds), it cannot track the physiologic calcium 
oscillations typical for neurons, but records only the low average 
baseline (≈100 nM) (14).
Microglia and astrocytes Mainly 
contribute to Oxidative stress after  
eae recovery
Next, we elucidated the specific cellular origin of the persis-
tent oxidative stress in the CNS during the remission phase. 
The approach used in our study  –  performing endogenous 
NAD(P)H–FLIM in the CNS of mice with differently fluoresc-
ing cell subsets (LysM+tdRFP, CerTNL15, CX3CR1+/− EGFP, or 
SR101 labeled cells) affected by EAE – enables the direct identifi-
cation of specific cellular origins of oxidative stress by examining 
colocalization of assembled NOX enzymes acquired via NAD(P)
H–FLIM with cellular markers visualized by fluorescence imag-
ing (Figures 4A,B).
We quantified the contribution of specific cell types to the total 
area of NOX enzymes activation in the CNS and found that the 
mean contribution of LysM+ phagocytes amounts to maximally 
4.3%, a value comparable to that of neurons (Thy1+ cells, 4.7%). 
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Whereas the contribution of neurons to the area of oxidative 
stress generation is, as expected, similar at peak EAE and during 
the remission phase, LysM+ phagocytes proved to be a major 
source of massive ROS production only during peak EAE but 
not during the remission, due to their low frequency within the 
CNS in this phase. Only few perivascular macrophages could be 
detected (Figure 4A, bottom panel) in line with the results of our 
FACS analysis in Figure 1A (5% of the cells are tdRFP expressing) 
and complementary to Figure 2A, in which no LysM tdRFP cell 
infiltration is shown after EAE recovery. LysM tdRFP cells can 
are located only in closest proximity to or within blood vessels 
(marked by white lines in Figure 4A) and are, even then, only 
partially activated (Figure 4A, bottom panel right image).
The main contribution to ROS production after recovery in 
EAE is associated with CX3CR1+ cells, i.e., 26%, and astrocytes 
(SR101), i.e., 45% (Figure  4B). Thus, microglia and astrocytes 
together contribute over 70% of the oxidative stress generation 
in remission of EAE. Since only in half of the microglia EGFP is 
detectable by intravital microscopy (heterozygous breeding) and 
not the entire astrocyte population takes up SR101 [i.e., only half 
of GFAP+ cells, namely GFAPlow (8)], the frequencies of microglia 
and astrocytes may well be underestimated, and we expect an 
even higher effective contribution of these cell types to oxidative 
stress.
DiscUssiOn
It is widely accepted that during chronic neuroinflammation, both 
in the human disease MS and in its murine model EAE, oxidative 
stress plays a major role in demyelination and neuronal damage 
(6–8). Most of the findings reported in EAE studies resulted from 
investigations during the peak of inflammation (17). After peak of 
disease, in C57BL/6 mice immunized with MOG35–55 peptide (7), 
clinical signs can resolve spontaneously (10, 17) or the mice enter a 
chronic phase with persistent paralysis (1). This pattern resembles 
features of the human disease MS, since in its relapsing-remitting 
phase (RRMS) symptoms are normally self-limiting and patients 
spontaneously recover.
Despite our knowledge about the dynamic processes of 
the acute immune response in the CNS, information about 
the reaction of the tissue after the inflammatory attack is very 
limited. The processes determining how and where new lesions 
occur are difficult to study in human tissue as the majority of 
the samples derives either from very early (biopsies) or very late 
(post-mortem) lesions. How lesions resolve, how progression 
takes place, and other characteristics of the later phases of the 
disease are not well understood (3, 18–20). The alterations of the 
immune system in MS lesions are obvious, but how this impacts 
the function of the CNS tissue is almost unknown. Only few 
inflammatory animal models focus on remyelination as a tissue 
response, e.g., studies using models of inflammatory cortical 
demyelination (18, 19).
In this study, we addressed the question of tissue dam-
age regarding oxidative stress as a major detrimental factor 
for the cells within CNS tissue and consecutive ongoing 
subclinical neuronal dysfunction after clinical remission of 
EAE signs. We observed that astrocytes and microglia are 
shifted toward an activated phenotype, showing both changes 
in morphology and, even more striking, a high level of acti-
vated NADPH oxidases correlating with persisting neuronal 
elevated calcium levels without evident morphological 
alterations. Hence, the consequences of sustained neuronal 
calcium levels after EAE recovery in contrast to peak of EAE 
are not clear yet (16). Could this be a reason for long-term 
neuronal damage leading to a progressive disease course in 
humans?
The role and fate of microglia/macrophages during neuro-
inflammation is still not well understood (10, 20). From BrdU 
studies, it was concluded that although microglia enter the cell 
cycle during acute inflammation, they return to quiescence fol-
lowing remission (21). Furthermore, gene expression analysis of 
microglia and macrophages suggested that after EAE recovery, 
these cells return toward homeostasis (10). In contrast, our data 
demonstrate that at least a subpopulation of microglia is not qui-
escent and still retains their activated function during remission, 
as demonstrated by their ameboid morphology and enhanced 
NOX activity in our model.
The results of our present study indicate that even after remis-
sion of the clinical signs, astroglial scars represent areas of ongo-
ing tissue damage, even in the absence of peripheral immune 
cells. Our findings support the idea of a “trapped” ongoing 
CNS inflammation as a mechanism of chronic progression in 
MS (2). At this phase of the disease, astrocytes and microglia 
alone are a source of persistent oxidative stress locally correlating 
with ongoing subclinical neuronal dysfunction, as measured by 
pathologically increased calcium levels in CerTN L15 ×  LysM 
tdRFP mice.
Our model provides a useful tool to further investigate the “tis-
sue memory” of neuroinflammatory processes, in order to better 
understand mechanisms of chronicity and disease progression 
in MS.
MaTerials anD MeThODs
Two-Photon laser-scanning Microscopy
Both fluorescence intensity and FLIM experiments were per-
formed using a specialized two-photon laser-scanning micro-
scope based on a commercial scan head (TriMScope, LaVision 
BioTec, Bielefeld, Germany). The detection of the fluorescence 
signals was accomplished either with photomultiplier tubes in the 
ranges 460 ± 30, 525 ± 25, 593 ± 20 nm or with a 16-channel par-
allelized TCSPC detector (FLIM-X16, LaVision BioTec, Bielefeld, 
Germany) in the range 460 ± 30 nm. The excitation of NADH and 
NADPH was performed at 760 nm (detection at 460 ± 30 nm), 
of Cerulean (detection at 460 ±  30  nm), SR101 (detection at 
593 ± 20 nm), and EGFP (detection at 525 ± 25 nm) at 850 or 
880 nm, and of tdRFP at 1110 nm (detection at 593 ± 20 nm).
For both intensity and fluorescence lifetime imaging, we used 
an average maximum laser power of 8 mW to avoid photodamage. 
The experimental parameters for FLIM were 160 ps histogram 
bin [for NAD(P)H–FLIM] and 80 ps histogram bin (for FRET–
FLIM) and maximum acquisition time for a 512 ×  512 image 
was 5 s to record a fluorescence decay stack. The time-window 
in which the fluorescence decays were acquired was set to 9 ns.
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Data analysis
Three-dimensional intravital images acquired within the brain 
stem of CX3CR1+/− EGFP mice, either healthy or affected by EAE, 
at peak and in the remission phase of the disease, were segmented 
using image analysis software (Imaris, BitPlane, UK). The 3D 
surfaces of the segmented cells (50–200 cells per condition) were 
transferred to Fiji/ImageJ and six orthogonal projections were 
generated for each cell. For each projection of each cell, the Fourier 
coefficients, describing the sphericity vs. ramification of the cell, 
were calculated (custom plug-in available in Fiji developed by 
Zoltan Cseresnyes). All Fourier coefficients corresponding to a 
single cell were merged following a linear algebraic combination 
to describe all ramifications of the cell (cell processes). The rank 
of the Fourier coefficients describes increasingly complex cellular 
ramifications: whereas the first Fourier coefficient corresponds to 
the first spherical approximation of the cell, the next coefficients 
describe increasingly longer processes.
Fluorescence lifetime imaging data analysis was performed 
using self-written software, as previously described (12, 14). The 
time-resolved fluorescence signal of NAD(P)H, as acquired by 
the TCSPC device, was approximated with a bi-exponential decay 
function (Eq. 1):
 
I a e a etNAD P H
t t
( )
− −= + +× ×( ) / /ε τ τ1 21 2  (1)
with ɛ the background, the 1-indexed term of the sum rep-
resenting the fluorescence decay of free NADH and NADPH 
and the 2-indexed term representing the fluorescence decay of 
enzyme-bound NADH and NADPH. The fluorescence lifetime 
τ1 [free NAD(P)H] is 400–450 ps, while the fluorescence lifetime 
τ2 of NAD(P)H bound to metabolic enzymes has an average of 
~2000 ps. If bound to NADPH oxidases (NOX1–4, DUOX1, 2), 
NADPH shows a typical fluorescence lifetime of 3650 ps, inde-
pendent of cell type and even of species, since we repeatedly 
measured this value in various cell types of humans, mice, 
and even plants (Nicotiana tabacum). We focused all through 
the manuscript on the fluorescence lifetime τ2 of the enzyme 
bound NAD(P)H.
As previously described, we define the area of neuronal 
dysfunction as the area of free neuronal calcium exceeding a 
concentration of 1 μM (14). The neuronal calcium concentra-
tion was measured in vivo using FLIM, in mice expressing the 
FRET-based calcium biosensor TN L15 in Thy1+ cells. Thereby, 
the time-resolved fluorescence decay of the donor in the FRET 
construct (Cerulean) was also approximated by a biexponential 
function (Eq. 2):
 I a e a etCerulean
t t( ) / /= + +× ×− −ε τ τ1 21 2  (2)
with ɛ the background, the 1-indexed term representing the fluo-
rescence decay of the FRET-quenched donor and the 2-indexed 
term representing the fluorescence decay of the unquenched 
donor. Here, we focused on the ratio a1/(a1 +  a2) of the rela-
tive concentrations of the FRET-quenched a1 and unquenched 
Cerulean a2, and, using our previously published calibration 
curve, we determined the absolute calcium concentration within 
neurons.
Statistical analysis and graphical presentation was carried 
out with GraphPad Prism 4 (Graphpad Software, USA) and 
OriginPro (OriginLab, USA). Results are shown as mean values 
from analyzed data per mouse, in addition the mean ± SD sum-
marize collective data from performed experiments.
Mice
All mice used were on a C57BL/6 background. The CerTN 
L15  ×  LysM tdRFP mouse expresses a FRET-based calcium 
biosensor consisting of Cerulean (donor) and Citrine (acceptor) 
bound to troponin C, a calcium-sensitive protein present in 
certain subsets of neurons (22). Additionally, tdRFP is expressed 
in LysM+ cells. The CX3CR1+/− EGFP mouse was used to detect 
microglia (Table 1).
eae induction
Experimental autoimmune encephalomyelitis was induced as 
previously described. Briefly, mice were immunized subcutane-
ously with 150 μg of MOG35–55 (Pepceuticals, UK) emulsified in 
CFA (BD Difco, Germany) and received 200 ng pertussis toxin 
(PTx, List Biological Laboratories, Inc.) intraperitoneally at the 
time of immunization and 48  h later. Intravital multi-photon 
microscopy was performed at different stages of the disease, i.e., 
peak (3–7 days after appearance of first clinical symptoms) and 
remission (after decline of clinical symptoms to a score ≤0.5). 
Mice were randomly picked for analysis. Detailed information 
about the performed EAE runs and individual scores of the mice 
are listed in Table 1. Mice at peak of disease were part of a previ-
ous study of Mossakowski et al. (8) and serve as a reference in 
this study. We did not included animals that never got sick and at 
onset analyzed animals.
Preparation of the Brain stem Window  
for intravital imaging
As previously described, the brain stem was exposed by carefully 
removing the musculature above the dorsal neck area and remov-
ing the dura mater between the first cervical vertebra and the 
occipital skull bone. The head was inclined for access to deeper 
brainstem regions and the brain stem superfused with isotonic 
Ringer solution. Anesthesia depth was controlled by continuous 
CO2 measurements of exhaled gas and recorded with a CI-240 
Microcapnograph (Columbus Instruments, USA) and by an 
Einthoven three-lead electrocardiogram (ECG). In order to avoid 
strong breathing artifacts in the brainstem of anesthetized mice, 
the ECG signal was correlated to the respiration rate and used as an 
external trigger for the image acquisition software, which controls 
the hardware of the microscope setup. Thus, each fluorescence 
stack was recorded at the same respiration state of the mouse and 
also in the same tissue region. Animal experiments were approved 
by the appropriate state committees for animal welfare (G0081/10, 
LAGeSo  –  Landesamt für Gesundheit und Soziales) and were 
performed in accordance with current guidelines and regulations.
Facs analysis
To isolate cells from the whole brain and spinal cord of LysM 
tdRFP mice, the tissue was homogenized after PBS perfusion, 
and a percoll gradient was performed according to standard 
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protocols with 25 and 75% stock istotonic percoll (GE Helthcare) 
and HBSS. Cells were blocked with antibodies to Fcγ receptors 
(DRFZ, clone 2.4G2) to avoid non-specific staining, and were 
subsequently stained with FITC-labeled PerCP-labled rat anti-
CD45 (BioLegend) or Cy5- (DRFZ), APC- or Pacific Blue™ 
(BioLegend)-labeled rat anti-CD11b, in some experiments fix-
able Viability Dye eFluor®780 (eBioscience), anti-CX3CR1 APC 
and anti-CD3 Brilliant Violet™ (both BioLegend) were used 
according to standard procedures, followed by fixation using 4% 
Paraformaldehyde (Electron Microscopy Science) for 10  min. 
FACS analysis was performed on a LSR Fortessa (BD).
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